The success of an «immunostimulatory« therapy for patients with tumour diseases essentially depends on the following points:
During immunostimulatory therapy (e.g. with preparations containing mistletoe, organs or microorganisms), the following laboratory parameters can be consulted to evaluate progress and prognosis. Following questions can be addressed:
The parameters mentioned are included in the quantitative immune profile «Immunocompetence Tumour« in addition to the recognised standard analyses such as CD4, CD8, NK and B cells and activated T cells.
Before immunostimulatory therapy
The repetition of the analyses 6-8 weeks after beginning immunostimulation answers the following questions:
Subsequently, while check-ups 4-8 months apart are recommended regardless of the clinical situation, one may be limited to the pathological findings in the initial diagnosis.
Medical finding at 6-week follow-up
LTT Immune Function:
20 ml heparin blood + 5 ml whole blood (serum)
NK cell cytotoxicity test:
10 ml heparin blood
Quantitative immune profile «Immunocompetence Tumour «
2 ml EDTA blood
5 ml heparin blood